Assessing Laser Photonics (LASE) Valuation After Defense And Medical Contract Wins

Laser Photonics Corp.

Laser Photonics Corp.

LASE

0.00

Laser Photonics (LASE) has drawn fresh attention after its Laser Shield Anti-Drone system advanced into a U.S. Department of War evaluation, along with a US$13.2 million follow on Navy order and a Johnson & Johnson medical laser contract.

The stock’s recent defense and medical contract wins sit alongside very sharp price moves, with a 7 day share price return of 288.45% and a 30 day share price return of 422.67% contrasting with a 3 year total shareholder return that is slightly below zero. This suggests short term momentum has picked up rapidly compared with a more mixed longer term experience.

If you are curious about where else advanced laser and automation themes are showing up in the market, this is a good moment to scan 33 robotics and automation stocks

With defense and medical wins arriving alongside sharp share price moves and ongoing losses of US$32.6 million on US$8.3 million of revenue, you have to ask: is there still value here, or is the market already pricing in future growth?

Preferred Price-to-Sales of 16.7x: Is it justified?

Laser Photonics trades on a P/S of 16.7x, while the broader US Machinery industry sits at 2.1x and close peers average 13.8x. That is a steep premium for a company that reported $8.3 million of revenue and a loss of $32.6 million, especially with no clear earnings or revenue forecasts available.

The P/S ratio compares the company’s market value with its sales, which can be useful when earnings are negative, as they are here. In this case, investors are effectively paying a much higher multiple of each dollar of current revenue than is typical for the sector, even though Laser Photonics is still loss making and there is insufficient data to assess future growth.

Compared with both the US Machinery industry’s 2.1x and the peer average of 13.8x, the 16.7x P/S stands out as materially richer than the pack. With no fair ratio available to suggest a level the valuation might gravitate toward, the premium appears to rest largely on current sentiment and expectations rather than any quantified benchmark.

Result: Price-to-Sales of 16.7x (OVERVALUED)

However, the story can turn quickly if contract momentum slows or ongoing losses of US$32.6 million make it harder to support a US$120.7 million valuation.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Next Steps

If the tone so far feels cautious, that is the point. Sharp moves and contract headlines can mask the full picture, so review the company’s 4 important warning signs

Looking for more investment ideas?

If Laser Photonics has your attention, do not stop here. Use this momentum to scan other focused stock ideas that might suit your watchlist and goals.

  • Spot potential value opportunities early by checking companies that screen well on quality and price using the 47 high quality undervalued stocks.
  • Strengthen the defensive side of your portfolio by focusing on companies with resilient finances via the solid balance sheet and fundamentals stocks screener (46 results).
  • Hunt for less crowded opportunities by reviewing the screener containing 22 high quality undiscovered gems before they are widely followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.